Evaluation of Joint Management of Pine Wood Waste and Residual Microalgae for Agricultural Application

Microalgae as a potential therapeutic drug candidate for neurodegenerative diseases

Microalgae are highly photosynthetic unicellular organism that have increased demand in the recent days owing to the presence of valuable cellular metabolites. They are ubiquitous in terrestrial and aquatic habitats, rich in species diversity and are capable of generating significant biomass by efficiently using CO₂, light and other nutrients like nitrogen, phosphate etc., The microalgal biomass has upsurged in economic potential and is used as both food and feed in many countries across the world, accounting for more than 75 % of annual microalgal biomass production in the past decades. The microalgal cells are sustainable resource that synthesize various secondary metabolites such as carotenoids, polysaccharides, polyphenols, essential amino acids, sterols, and polyunsaturated fatty acids (PUFA). Microalgae and its derived compounds possess significant pharmacological and biological effects such as antioxidant, anti-inflammatory, anti-cancer, immunomodulatory and anti-obesity. Because of their potential health promoting properties, the utilization of microalgae and its derived substances in food, pharmaceutical and cosmetic industries has skyrocketed in recent years. In this context, the current review discusses about the benefits of microalgae and its bioactive compounds against several neurodegenerative disorders like Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS).

Promoting Sustainability: Wastewater Treatment Plants as a Source of Biomethane in Regions Far from a High-Pressure Grid. A Real Portuguese Case Study

Wastewater treatment plants (WWTP) located in regions far from a high-pressure grid can produce renewable biomethane, which can partially substitute the natural gas locally consumed. However, the economic viability of implementing biomethane plants in WWTP has to be guaranteed. This paper uses the discount cash flow method to analyze the economic viability of producing biomethane in a WWTP located in Évora (Portugal). The results show that, under the current conditions, it is unprofitable to produce biomethane in this WWTP. Since selling the CO2 separated from biogas may result in an additional income, this option was also considered. In this case, a price of 46 EUR/t CO2 has to be paid to make the project viable. Finally, the impact of potential government incentives in the form of feed-in premia was investigated. Without selling CO2, the project would only be profitable for feed-in premia above 55.5 EUR/MWh. If all the CO2 produced was sold at 30 EUR/t CO2, a premium price of 20 EUR/MWh would make the project profitable. This study shows that the economic attractiveness of producing biomethane in small WWTP is only secured through sufficient financial incentives, which are vital for developing the biomethane market with all its associated advantages.

Microalgal Cell Biofactory-Therapeutic, Nutraceutical and Functional Food Applications

Microalgae are multifaceted photosynthetic microorganisms with emerging business potential. They are present ubiquitously in terrestrial and aquatic environments with rich species diversity and are capable of producing significant biomass. Traditionally, microalgal biomass is being used as food and feed in many countries around the globe. The production of microalgal-based bioactive compounds at an industrial scale through biotechnological interventions is gaining interest more recently. The present review provides a detailed overview of the key algal metabolites, which plays a crucial role in nutraceutical, functional foods, and animal/aquaculture feed industries. Bioactive compounds of microalgae known to exhibit antioxidant, antimicrobial, antitumor, and immunomodulatory effects were comprehensively reviewed. The potential microalgal species and biological extracts against human pathogens were also discussed. Further, current technologies involved in upstream and downstream bioprocessing including cultivation, harvesting, and cell disruption were documented. Establishing microalgae as an alternative supplement would complement the sustainable and environmental requirements in the framework of human health and well-being.